Latest Insights - page 91 | BiopharmaTrend

Unveiling Hidden Drug Targets

Scientists estimated that the human genome encodes above 20,000 different proteins in our body. However, available public databases contain records of known ligands for only about 10% of all proteins. …

Continue ›››

Chinese Biotech Innovent Biologics, Inc. Raises USD 260M To Accelerate Biologics Development

Chinese biopharmaceutical industry investment landscape has been marked by a new record -- USD $260M Series D investment raised by Innovent Biologics, Inc. exceeded China's previous investment deals for biopharmaceutical …

Continue ›››

Learning From Nature: New Antibiotics Found In Our Body

To date, nature has been the best teacher for drug discovery scientists, especially for those who develop antimicrobial drugs. Lately, a new example proving this notion emerged in press - …

Continue ›››

A New Player In The Area Of Anti-inflammatory Therapeutics: Biotech Startup Inflazome To Tackle The Problem

Understanding and controlling inflammation processes has become a central goal in modern medical research. A number of companies developing novel anti-inflammatory drugs has emerged to grow on the wave of …

Continue ›››

A Drug Repurposing Case By Biotech Startup Forty Seven Inc

Drug repositioning is a smart and cost-effective approach used by some pharmaceutical companies to re-invent their previously successful drugs in a new role and generate extra value from existing assets. …

Continue ›››

Cross-Coupling Hits The Big Time Again

Recently, a series of papers emerged in scientific press significantly expanding capabilities of classical carbon-heteroatom cross-coupling reactions making them simpler, cheaper, and efficient across a much broader range of substrates. …

Continue ›››

A Second Chance for Integrins: Biotech Startup Morphic Therapeutic Reinvents Old Target

Integrins are a group of transmembrane receptors playing a major role in cell-cell and cell-extracellular matrix (ECM) interactions. When triggered, integrin receptors transduce signals to the interior of the cell, …

Continue ›››

What Chemicals Are Popular Among Medicinal Chemists?

Increasing the success rate of high-throughput screening (HTS) and the quality of the resulting hits as well as developability of drug candidates is among the key challenges of small molecule …

Continue ›››

Facebook and Napster founder Sean Parker is going to “hack cancer” by CRISPR technology

A billionaire Sean Parker, known as a founder of Facebook and Napster, has steeply entered Life Sciences industry to fund the world’s first-ever CRISPR/Cas9 trial, backed by US federal authorities. …

Continue ›››